- Home
- Publications
- Publication Search
- Publication Details
Title
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 5, Pages 735-750
Publisher
Wiley
Online
2016-01-06
DOI
10.1016/j.molonc.2015.12.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activated Stat-3 in Melanoma
- (2017) Jane L. Messina et al. Cancer Control
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- HDAC inhibitors and immunotherapy; a double edged sword?
- (2015) Michiel Kroesen et al. Oncotarget
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
- (2014) Fengdong Cheng et al. JOURNAL OF IMMUNOLOGY
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
- (2014) Fengdong Cheng et al. MOLECULAR IMMUNOLOGY
- Emerging trends in the epidemiology of melanoma
- (2013) V. Nikolaou et al. BRITISH JOURNAL OF DERMATOLOGY
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Role and Regulation of STAT3 Phosphorylation at Ser727 in Melanocytes and Melanoma Cells
- (2012) Masanobu Sakaguchi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
- (2011) Karrune V Woan et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- The Down-regulation of the Human MYC Gene by the Nuclear Hormone 1α,25-dihydroxyvitamin D3 is Associated with Cycling of Corepressors and Histone Deacetylases
- (2010) Sari Toropainen et al. JOURNAL OF MOLECULAR BIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histone Deacetylases Suppress CGG Repeat–Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome
- (2010) Peter K. Todd et al. PLoS Genetics
- HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
- (2009) Sumihito Togi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
- (2009) Ana Palijan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recruitment of cAMP-response Element-binding Protein and Histone Deacetylase Has Opposite Effects on Glucocorticoid Receptor Gene Transcription
- (2009) Manjapra Variath Govindan JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylases and the immunological network: implications in cancer and inflammation
- (2009) A Villagra et al. ONCOGENE
- Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution
- (2008) S. Ray et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now